| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 2.80 | 0.00 (0.00%) | 2.21 - 3.20 | 63.5 thousand (Below Avg) |
Market data as of 4:01PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 2.80 |
|---|---|
| Previous Close | 2.80 |
| Day's Range | 2.79 - 2.84 |
| Market Cap | 204.8M |
| Avg Volume (10 Day) | 70.4K |
| Price/Earnings (Trailing 12 Mo.) | 11.3x |
| Earnings Per Share (Trailing 12 Mo.) | 0.25 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Fail |
| Stock is undervalued? | Pass |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
No news headlines available for CO
| CO | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 33.12% | |
| Net Income Growth (1yr) | -5.52% | |
| Total Debt/Equity | 0.67 | |
| LT Debt/Equity | 0.62 | |
| Earnings Yield | 8.85% | |
| Price/Sales | 2.61 |
| Company | Last | Change |
|---|---|---|
| Neogenomics Inc | 3.60 | -4.76% |
| Alliance HealthCare Services Inc | 12.82 | +0.16% |
| TearLab Corp | 10.07 | -2.04% |
| RadNet Inc | 2.38 | -2.46% |
| LipoScience Inc | 6.19 | +0.65% |
Data is delayed by at least 15 min.